Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
University of Alabama at Birmingham
Medical College of Wisconsin
Seattle Children's Hospital
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Novartis
Valent Technologies, LLC
Engeneic Pty Limited
Kian Immune Cell Company
Baylor College of Medicine
New Approaches to Neuroblastoma Therapy Consortium
Nanjing Children's Hospital
Blueprint Medicines Corporation
Milton S. Hershey Medical Center
Celgene
St. Jude Children's Research Hospital
University of California, San Francisco
Dana-Farber Cancer Institute
Emory University
AbbVie
H. Lee Moffitt Cancer Center and Research Institute
Columbia University
South Plains Oncology Consortium
South Plains Oncology Consortium
Eli Lilly and Company
Cancer Research UK
Xuanwu Hospital, Beijing
Oncurious NV
Emory University
National Institutes of Health Clinical Center (CC)
The Hospital for Sick Children
Children's Mercy Hospital Kansas City
University of California, San Francisco
The Methodist Hospital Research Institute
Children's Mercy Hospital Kansas City
Clinica Universidad de Navarra, Universidad de Navarra
University of Louisville
University of Louisville
University Hospital, Bonn
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Children's Oncology Group
Angiochem Inc
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Baylor College of Medicine